↓ Skip to main content

Dove Medical Press

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
facebook
1 Facebook page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
28 Mendeley
Title
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
Published in
Neuropsychiatric Disease and Treatment, August 2019
DOI 10.2147/ndt.s173567
Pubmed ID
Authors

Justin Faden, Leslie Citrome

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 14%
Researcher 3 11%
Professor > Associate Professor 3 11%
Other 2 7%
Student > Master 1 4%
Other 3 11%
Unknown 12 43%
Readers by discipline Count As %
Medicine and Dentistry 6 21%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Economics, Econometrics and Finance 2 7%
Biochemistry, Genetics and Molecular Biology 1 4%
Computer Science 1 4%
Other 3 11%
Unknown 13 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2020.
All research outputs
#4,264,391
of 25,385,509 outputs
Outputs from Neuropsychiatric Disease and Treatment
#590
of 3,131 outputs
Outputs of similar age
#79,666
of 359,381 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#17
of 109 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,381 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.